Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1959 • 47,127 citations

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1992 • 2,216 citations

Molecular physiology of reverse cholesterol transport.

1995 • 1,452 citations

Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein

1988 • 643 citations

Novel purification of vitronectin from human plasma by heparin affinity chromatography.

1988 • 525 citations

Cholesterol transport between cells and high-density lipoproteins

1991 • 451 citations

[8] Single vertical spin density gradient ultracentrifugation

1986 • 449 citations

Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.

1989 • 412 citations

High density lipoproteins and coronary heart disease

1996 • 386 citations

Clusterin: the intriguing guises of a widely expressed glycoprotein

1992 • 353 citations

Apolipoprotein-mediated removal of cellular cholesterol and phospholipids

1996 • 346 citations

Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

1991 • 331 citations

Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.

1982 • 296 citations

Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents

1980 • 279 citations

A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins.

1990 • 260 citations

A Method for Defining the Stages of Low-Density Lipoprotein Oxidation by the Separation of Cholesterol and Cholesteryl Ester-Oxidation Products Using HPLC

1993 • 221 citations

Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages

1996 • 179 citations

Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.

1993 • 177 citations

Sterol to Phospholipid Molar Ratios of L Cells with Qualitative and Quantitative Variations of Cellular Sterol

1974 • 132 citations

Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol

1996 • 130 citations

Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT

1995 • 120 citations

SP-40,40 is an inhibitor of C5b-6-initiated haemolysis

1989 • 115 citations

Potent Inhibition of Terminal Complement Assembly by Clusterin: Characterization of Its Impact on C9 Polymerization

1997 • 101 citations

Apolipoprotein A-I–Mediated Efflux of Sterols From Oxidized LDL–Loaded Macrophages

1995 • 96 citations

Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG

1992 • 89 citations

Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis.

1994 • 80 citations

Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.

1995 • 75 citations

Presence and Formation of ‘Free Apolipoprotein A-I–Like’ Particles in Human Plasma

1995 • 72 citations

Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions.

1993 • 68 citations

Clusterin: an enigmatic protein recruited by diverse stimuli.

1993 • 61 citations

Structure and stability of apolipoprotein J-containing high-density lipoproteins

1992 • 38 citations

Interaction of apolipoprotein A-II with recombinant HDL containing egg phosphatidylcholine, unesterified cholesterol and apolipoprotein A-I

1990 • 33 citations

Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies.

1994 • 31 citations